Case Report: A Child With Hemophilia A Serves as Donor for Hematopoietic Stem Cell Transplantation to Cure His Brother's Severe Aplastic Anemia

Pathol Oncol Res. 2022 Jun 8:28:1610171. doi: 10.3389/pore.2022.1610171. eCollection 2022.

Abstract

The first-line treatment of severe aplastic anemia is allogeneic hematopoietic stem cell transplantation with a matched sibling donor. However, co-morbidities of the identical donor can make donation difficult. We present a transplantation where in parallel with the patient's conditioning treatment, the preparation of the donor with severe hemophilia A required a special management with perioperative factor VIII substitution. Donation was successful without complications, and 18 months after transplantation, the patient and his donor are well without any long-term sequelae. To our knowledge, this is the first reported succesfull transplantation with hemophilic child serving as a bone marrow donor. The procedure did not mean a significant risk to donor health, so donors with hemophilia should not be excluded from donation.

Keywords: children; hematopoietic stem cell transplantation (HSCT); hemophilia a; hepatitis associated bone marrow failure (HABMF); severe aplastic anemia (SAA).

Publication types

  • Case Reports

MeSH terms

  • Anemia, Aplastic* / therapy
  • Child
  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation*
  • Hemophilia A* / complications
  • Hemophilia A* / therapy
  • Humans
  • Male
  • Siblings
  • Transplantation Conditioning